These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15717164)

  • 1. The response to cyclophosphamide in steroid-sensitive nephrotic syndrome is influenced by polymorphic expression of glutathion-S-transferases-M1 and -P1.
    Vester U; Kranz B; Zimmermann S; Büscher R; Hoyer PF
    Pediatr Nephrol; 2005 Apr; 20(4):478-81. PubMed ID: 15717164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do glutathione-S-transferase polymorphisms influence response to intravenous cyclophosphamide therapy in idiopathic nephrotic syndrome?
    Sharda SV; Gulati S; Tripathi G; Jafar T; Kumar A; Sharma RK; Agrawal S
    Pediatr Nephrol; 2008 Nov; 23(11):2001-6. PubMed ID: 18594869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclophosphamide in steroid-sensitive nephrotic syndrome: outcome and outlook.
    Vester U; Kranz B; Zimmermann S; Hoyer PF
    Pediatr Nephrol; 2003 Jul; 18(7):661-4. PubMed ID: 12750975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up after cyclophosphamide therapy in steroid-dependent nephrotic syndrome.
    Zagury A; de Oliveira AL; de Moraes CA; de Araujo Montalvão JA; Novaes RH; de Sá VM; Monteiro de Carvalho Dde B; Matuck T
    Pediatr Nephrol; 2011 Jun; 26(6):915-20. PubMed ID: 21399901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial.
    Ponticelli C; Edefonti A; Ghio L; Rizzoni G; Rinaldi S; Gusmano R; Lama G; Zacchello G; Confalonieri R; Altieri P
    Nephrol Dial Transplant; 1993; 8(12):1326-32. PubMed ID: 8159300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutathione-S-transferase genotypes and the adverse effects of azathioprine in young patients with inflammatory bowel disease.
    Stocco G; Martelossi S; Barabino A; Decorti G; Bartoli F; Montico M; Gotti A; Ventura A
    Inflamm Bowel Dis; 2007 Jan; 13(1):57-64. PubMed ID: 17206640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment course of steroid-dependent nephrotic syndrome: emphasized on treatment effect.
    Chen SY; Wu CY; Tsai IJ; Tsau YK
    Nephrology (Carlton); 2010 Apr; 15(3):336-9. PubMed ID: 20470303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephrotic syndrome.
    Kyrieleis HA; Levtchenko EN; Wetzels JF
    Am J Kidney Dis; 2007 May; 49(5):592-7. PubMed ID: 17472840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutathione S-transferase enzyme expression in hematopoietic cell lines implies a differential protective role for T1 and A1 isoenzymes in erythroid and for M1 in lymphoid lineages.
    Wang L; Groves MJ; Hepburn MD; Bowen DT
    Haematologica; 2000 Jun; 85(6):573-9. PubMed ID: 10870112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up after cyclophosphamide and cyclosporine-A therapy in steroid-dependent and -resistant nephrotic syndrome.
    Sümegi V; Haszon I; Bereczki C; Papp F; Túri S
    Pediatr Nephrol; 2008 Jul; 23(7):1085-92. PubMed ID: 18324421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cyclophosphamide in idiopathic nephrotic syndrome: Outcome and outlook].
    Berkane M; Adarmouch L; Amine M; Bourrahouat A; Ait Sab I; Sbihi M
    Nephrol Ther; 2018 Apr; 14(2):85-90. PubMed ID: 29631702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between long-term neuro-toxicities in testicular cancer survivors and polymorphisms in glutathione-s-transferase-P1 and -M1, a retrospective cross sectional study.
    Oldenburg J; Kraggerud SM; Brydøy M; Cvancarova M; Lothe RA; Fossa SD
    J Transl Med; 2007 Dec; 5():70. PubMed ID: 18162130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutathione S-transferase M1, T1 and P1 polymorphisms: susceptibility and outcome in lung cancer patients.
    Sreeja L; Syamala V; Hariharan S; Syamala VS; Raveendran PB; Sivanandan CD; Madhavan J; Ankathil R
    J Exp Ther Oncol; 2008; 7(1):73-85. PubMed ID: 18472644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclophosphamide and rituximab in frequently relapsing/steroid-dependent nephrotic syndrome.
    Webb H; Jaureguiberry G; Dufek S; Tullus K; Bockenhauer D
    Pediatr Nephrol; 2016 Apr; 31(4):589-94. PubMed ID: 26525199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutathione S Transferases Polymorphisms Are Independent Prognostic Factors in Lupus Nephritis Treated with Cyclophosphamide.
    Audemard-Verger A; Martin Silva N; Verstuyft C; Costedoat-Chalumeau N; Hummel A; Le Guern V; Sacré K; Meyer O; Daugas E; Goujard C; Sultan A; Lobbedez T; Galicier L; Pourrat J; Le Hello C; Godin M; Morello R; Lambert M; Hachulla E; Vanhille P; Queffeulou G; Potier J; Dion JJ; Bataille P; Chauveau D; Moulis G; Farge-Bancel D; Duhaut P; Saint-Marcoux B; Deroux A; Manuzak J; Francès C; Aumaitre O; Bezanahary H; Becquemont L; Bienvenu B
    PLoS One; 2016; 11(3):e0151696. PubMed ID: 27002825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined glutathione-S-transferase M1 and T1 genetic polymorphism and tacrine hepatotoxicity.
    Simon T; Becquemont L; Mary-Krause M; de Waziers I; Beaune P; Funck-Brentano C; Jaillon P
    Clin Pharmacol Ther; 2000 Apr; 67(4):432-7. PubMed ID: 10801254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up in children with steroid-resistant nephrotic syndrome.
    Besbas N; Topaloglu R; Saatci O; Bakkaloglu A
    Clin Pediatr (Phila); 1992 May; 31(5):283-8. PubMed ID: 1582094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutathione S transferase (GSTP 1, GSTM 1, and GSTT 1) gene polymorphisms in Egyptian patients with acute myeloid leukemia.
    Nasr AS; Sami RM; Ibrahim NY; Darwish DO
    Indian J Cancer; 2015; 52(4):490-5. PubMed ID: 26960454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cyclosporin A versus cyclophosphamide in the treatment of nephrotic syndrome in children].
    Podracká L; Böör A; Sasinka M
    Cas Lek Cesk; 2008; 147(1):38-43. PubMed ID: 18323041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutathione S-transferase M1, T1, and P1 polymorphisms and survival among lung cancer patients.
    Sweeney C; Nazar-Stewart V; Stapleton PL; Eaton DL; Vaughan TL
    Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):527-33. PubMed ID: 12814998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.